ARTEA risk profile
87 Acute at or past the historical limit
Measured 21 October 2026 from ARTE.PA's filed statements. Recomputed nightly.
87 (Acute), driven by Cash conversion at 100, over 5 weighted categories on the GENERAL profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 74 | Stretched | Stable | Drawdown from the 52-week high — 37.1% |
| Operating pressure | 77 | Stretched | Worsening | Costs outgrowing revenue — +10.5 percentage points |
| Cash conversion | 100 | Acute | Worsening | Capital spending against operating cash — -0.10x |
| Leverage and coverage | 100 | Acute | Worsening | Net debt to EBITDA |
| Competitive position | 86 | Acute | Stable | Operating-margin gap against peers — -22.5 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.